665881 tn?1248926997

Important development in the treatment of multiple sclerosi.

A major step forward, with important implications for understanding how to reduce the severity of multiple sclerosis, has been made by scientists at the University of Bristol. The results are published online today in PNAS.

The team found that mice designed to express a large amount of the neuropeptide ‘galanin’ were completely resistant to the MS-like disease, experimental autoimmune encephalomyelitis (EAE). Transgenic mice that contained no galanin at all developed a more severe form of the disease.

Subsequent tests on human brain tissue affected by MS showed galanin to be specifically upregulated in MS lesions and shadow plaques, which are often seen in acute MS.

These important results suggest that galanin could have future therapeutic implications for multiple sclerosis.

Professor David Wynick who initiated the research and works on the function of galanin in the relief of neuropathic pain said: “It has been known for some time that galanin plays a protective role in both the central and peripheral nerve systems; when a nerve is injured levels of galanin increase dramatically in an attempt to limit cell death.

“When I heard that someone had shown galanin was upregulated in Alzheimer’s disease, I decided to investigate if it was also important in MS. To do this I formed a collaboration with Professors David Wraith and Neil Scolding who both work on MS.”

Wraith, who is working on a vaccine for the treatment of multiple sclerosis, investigated the MS-like disease in the various galanin transgenic mice developed in the Wynick lab.

Professor Wraith said: “The results were really remarkable: rarely do you see such a dramatic effect as this. Mice with high levels of galanin just didn’t develop any signs of disease. We have a lot more to do to figure out how this works but the results are extremely promising.”

Wynick then turned to Professor Neil Scolding who studies the use of stem cells in the treatment of multiple sclerosis. Scolding provided human brain tissue affected by multiple sclerosis and, as the team predicted, galanin was also shown to be upregulated in this brain tissue.

Professor Scolding said: “The results of this research are very significant and provide new insights into how the disease might be treated”.

Although these early results are very encouraging there is still a large amount of work to be done before a drug can be developed to help MS sufferers, and it will be at least 10 years before such a drug is on the market.

Professor Wynick’s spin-out company, NeuroTargets, owns the intellectual property relating to this work and it will be seeking the substantial funding needed to advance these findings.
5 Responses
Sort by: Helpful Oldest Newest
665881 tn?1248926997
Im not really sure what they are getting at with this??
Here is the site i got it off -------> http://www.news-medical.net/news/20090826/Important-development-in-the-treatment-of-multiple-sclerosis.aspx
Helpful - 0
338416 tn?1420045702
Don't forget that this is still EAE, not actually multiple sclerosis.
Helpful - 0
751951 tn?1406632863
BBC basically rephrases the story:


The gist is that this research might lead to a treatment down the road, but we're talking a decade, anyway.  Still, anything that contributes to understanding the disease has to be seen as a positive.
Helpful - 0
572651 tn?1530999357
and this is in mice - and mice don't get MS..... people do.  Erin, I know you want to be excited about this, but there are lots of other developments that give us hope too.  Don't get down waiting for a cure, ok?  

Helpful - 0
319532 tn?1250988576
Well on a more positive note, lets not forget that an elevated amount of galanin was also discovered in the post mortems of human brain tissue. Yes its EAE but remember, its been used worldwide for a reason so lets wait n see...
Helpful - 0
Have an Answer?

You are reading content posted in the Multiple Sclerosis Community

Top Neurology Answerers
987762 tn?1331027953
5265383 tn?1483808356
1756321 tn?1547095325
Queensland, Australia
1780921 tn?1499301793
Queen Creek, AZ
Learn About Top Answerers
Didn't find the answer you were looking for?
Ask a question
Popular Resources
Find out how beta-blocker eye drops show promising results for acute migraine relief.
In this special Missouri Medicine report, doctors examine advances in diagnosis and treatment of this devastating and costly neurodegenerative disease.
Here are 12 simple – and fun! – ways to boost your brainpower.
Discover some of the causes of dizziness and how to treat it.
Discover the common causes of headaches and how to treat headache pain.
Two of the largest studies on Alzheimer’s have yielded new clues about the disease